Turning scientific innovation into strategic partnerships.
We help clients identify, assess, and execute partnerships that unlock scientific and commercial value. Our team provides end-to-end advisory across asset scouting, due diligence, valuation, and transaction structuring. With deep domain expertise and cross-border experience, JRC ensures every collaboration is built on aligned interests, sound valuation, and long-term growth potential.
In-licensing & Asset Scouting
JRC identifies and evaluates high-potential technologies and clinical assets for in-licensing or co-development. We combine scientific diligence with market analytics to assess differentiation, development risk, and commercial scalability. Our cross-regional access across the U.S., Europe, and Asia enables clients to discover opportunities others overlook.
Due Diligence Consulting
We conduct multidimensional due diligence that integrates science, clinical design, IP, regulatory feasibility, and market outlook. Our structured framework quantifies development risk and commercial upside, providing clear recommendations to investors and corporate decision-makers. Each review delivers actionable insight that strengthens negotiation leverage and post-deal execution confidence.
Valuations
JRC builds valuation models grounded in scientific milestones and market dynamics rather than simple financial comparables. We apply risk-adjusted NPV, scenario analysis, and comparable transaction benchmarking to define realistic asset value ranges. Our independent assessments guide deal pricing, investment entry points, and portfolio reprioritization.